These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Intentional ablation of vestibular function using commercially available topical gentamicin-betamethasone eardrops in patients with Meniere's disease: further evidence for topical eardrop ototoxicity. Kaplan DM; Hehar SS; Bance ML; Rutka JA Laryngoscope; 2002 Apr; 112(4):689-95. PubMed ID: 12150525 [TBL] [Abstract][Full Text] [Related]
5. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease. Wu IC; Minor LB Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316 [TBL] [Abstract][Full Text] [Related]
6. [Follow-up assessment of intratympanic gentamicin therapy and Saccotomia in Menière's Disease]. Tauber S; Jäger L; Issing WJ Laryngorhinootologie; 2002 May; 81(5):335-41. PubMed ID: 12001022 [TBL] [Abstract][Full Text] [Related]
7. Long-term results after interval therapy with intratympanic gentamicin for Menière's disease. Lange G; Maurer J; Mann W Laryngoscope; 2004 Jan; 114(1):102-5. PubMed ID: 14710003 [TBL] [Abstract][Full Text] [Related]
8. [Intratympanic gentamycin in association with human fibrin glue in the treatment of Meniere's disease: preliminary results]. Casani AP; Dallan I; Sellari-Franceschini S; Nuti D Acta Otorhinolaryngol Ital; 2002 Aug; 22(4):199-207. PubMed ID: 12379040 [TBL] [Abstract][Full Text] [Related]
9. Long-term disability of class A patients with Ménière's disease after treatment with intratympanic gentamicin. Boleas-Aguirre MS; Sánchez-Ferrandiz N; Guillén-Grima F; Perez N Laryngoscope; 2007 Aug; 117(8):1474-81. PubMed ID: 17607149 [TBL] [Abstract][Full Text] [Related]
10. Intratympanic gentamicin therapy for intractable Ménière's disease. De Beer L; Stokroos R; Kingma H Acta Otolaryngol; 2007 Jun; 127(6):605-12. PubMed ID: 17503229 [TBL] [Abstract][Full Text] [Related]
11. Transtympanic gentamicin and fibrin tissue adhesive for treatment of unilateral Menière's disease: effects on vestibular function. Casani A; Nuti D; Franceschini SS; Gaudini E; Dallan I Otolaryngol Head Neck Surg; 2005 Dec; 133(6):929-35. PubMed ID: 16360516 [TBL] [Abstract][Full Text] [Related]
12. Intratympanic gentamicin therapy for vertigo in nonserviceable ears. Bauer PW; MacDonald CB; Cox LC Am J Otolaryngol; 2001; 22(2):111-5. PubMed ID: 11283825 [TBL] [Abstract][Full Text] [Related]
13. Low-dose intratympanic gentamicin treatment for dizziness in Ménière's disease. Longridge NS; Mallinson AI J Otolaryngol; 2000 Feb; 29(1):35-9. PubMed ID: 10709170 [TBL] [Abstract][Full Text] [Related]
14. Auditory results after vestibular nerve section and intratympanic gentamicin for Ménière's disease. Colletti V; Carner M; Colletti L Otol Neurotol; 2007 Feb; 28(2):145-51. PubMed ID: 17255880 [TBL] [Abstract][Full Text] [Related]
15. Intratympanic gentamicin for Ménière's disease: effect on quality of life as assessed by Glasgow benefit inventory. Banerjee AS; Johnson IJ J Laryngol Otol; 2006 Oct; 120(10):827-31. PubMed ID: 16707038 [TBL] [Abstract][Full Text] [Related]
16. [Meniere's disease: diagnosis and new treatment perspectives]. Quaranta A; Piazza F Recenti Prog Med; 2000 Jan; 91(1):33-7. PubMed ID: 10705783 [TBL] [Abstract][Full Text] [Related]
17. Vestibular function at the end of intratympanic gentamicin treatment of patients with Ménière's disease. Perez N; Rama-Lopez J J Vestib Res; 2005; 15(1):49-58. PubMed ID: 15908740 [TBL] [Abstract][Full Text] [Related]